Cartesian Therapeutics (RNAC) Insider Trading & Ownership $18.47 -0.88 (-4.55%) (As of 12/24/2024 02:33 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cartesian Therapeutics (NASDAQ:RNAC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage57.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2.38 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$2.17 M Get RNAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RNAC Insider Buying and Selling by Quarter Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Cartesian Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/21/2024Metin KurtogluCTOSell32,789$16.67$546,592.63 11/18/2024Metin KurtogluCTOSell34,400$18.39$632,616.00 11/14/2024Metin KurtogluCTOSell25,900$16.44$425,796.00 11/14/2024Milos MiljkovicInsiderSell35,000$16.13$564,550.00 10/4/2024Timothy A SpringerDirectorBuy80,301$22.58$1,813,196.58 10/2/2024Timothy A SpringerDirectorBuy5,514$17.38$95,833.32 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/12/2024Timothy A SpringerDirectorBuy8,016$12.72$101,963.52 3/18/2024Timothy A SpringerDirectorBuy634$18.00$11,412.00 3/14/2024Timothy A SpringerDirectorBuy21,612$16.20$350,114.40 3/11/2024Timothy A SpringerDirectorBuy40$19.50$780.00 3/8/2024Timothy A SpringerDirectorBuy160$19.80$3,168.00 2/6/2024Timothy A SpringerDirectorBuy26$19.50$507.00 1/17/2024Timothy A SpringerDirectorBuy26$20.70$538.20 (Data available from 1/1/2013 forward) RNAC Insider Trading Activity - Frequently Asked Questions Who is on Cartesian Therapeutics's Insider Roster? The list of insiders at Cartesian Therapeutics includes Metin Kurtoglu, Milos Miljkovic, and Timothy A Springer. Learn more on insiders at RNAC. What percentage of Cartesian Therapeutics stock is owned by insiders? 57.90% of Cartesian Therapeutics stock is owned by insiders. Learn more on RNAC's insider holdings. Which Cartesian Therapeutics insiders have been buying company stock? The following insider purchased RNAC shares in the last 24 months: Timothy A Springer ($2,377,513.02). How much insider buying is happening at Cartesian Therapeutics? Insiders have purchased a total of 116,329 RNAC shares in the last 24 months for a total of $2,377,513.02 bought. Which Cartesian Therapeutics insiders have been selling company stock? The following insiders have sold RNAC shares in the last 24 months: Metin Kurtoglu ($1,605,004.63), and Milos Miljkovic ($564,550.00). How much insider selling is happening at Cartesian Therapeutics? Insiders have sold a total of 128,089 Cartesian Therapeutics shares in the last 24 months for a total of $2,169,554.63 sold. Cartesian Therapeutics Key ExecutivesDr. Carsten Brunn Ph.D. (Age 53)President, CEO & Director Compensation: $4.67MMr. Blaine T. Davis (Age 50)Chief Financial Officer Compensation: $2.49MDr. Metin Kurtoglu M.D. (Age 45)Ph.D., Chief Technology Officer Compensation: $398.28kDr. Chris Jewell Ph.D. (Age 42)Chief Scientific Officer Compensation: $296.85kMr. Matthew Bartholomae J.D.General Counsel & SecretaryDr. Milos Miljkovic M.D. (Age 40)Ph.D., Chief Medical Officer Dr. Emily English Ph.D. (Age 44)SVP & Head of Manufacturing Mr. Yi Zhang Ph.D.Senior Director of Technology More Insider Trading Tools from MarketBeat Related Companies IRON Insider Buying AMPH Insider Buying IBRX Insider Buying ARQT Insider Buying XNCR Insider Buying KNSA Insider Buying RCUS Insider Buying PRAX Insider Buying NRIX Insider Buying IMCR Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:RNAC) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNAC Stock Alerts